- Home
- BLNK vs SCPH Comparison
BLNK vs SCPH Comparison
Compare BLNK & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLNK
- SCPH
- Stock Information
- Founded
- BLNK 2009
- SCPH 2013
- Country
- BLNK United States
- SCPH United States
- Employees
- BLNK N/A
- SCPH N/A
- Industry
- BLNK Industrial Specialties
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- BLNK Consumer Discretionary
- SCPH Health Care
- Exchange
- BLNK Nasdaq
- SCPH Nasdaq
- Market Cap
- BLNK 129.3M
- SCPH 299.0M
- IPO Year
- BLNK N/A
- SCPH 2017
- Fundamental
- Price
- BLNK $1.36
- SCPH $5.63
- Analyst Decision
- BLNK Buy
- SCPH Buy
- Analyst Count
- BLNK 8
- SCPH 3
- Target Price
- BLNK $2.54
- SCPH $12.00
- AVG Volume (30 Days)
- BLNK 3.4M
- SCPH 2.4M
- Earning Date
- BLNK 11-06-2025
- SCPH 11-12-2025
- Dividend Yield
- BLNK N/A
- SCPH N/A
- EPS Growth
- BLNK N/A
- SCPH N/A
- EPS
- BLNK N/A
- SCPH N/A
- Revenue
- BLNK $104,788,000.00
- SCPH $49,969,000.00
- Revenue This Year
- BLNK N/A
- SCPH $104.30
- Revenue Next Year
- BLNK $19.30
- SCPH $76.06
- P/E Ratio
- BLNK N/A
- SCPH N/A
- Revenue Growth
- BLNK N/A
- SCPH 107.79
- 52 Week Low
- BLNK $0.63
- SCPH $1.94
- 52 Week High
- BLNK $2.32
- SCPH $6.28
- Technical
- Relative Strength Index (RSI)
- BLNK 70.55
- SCPH 63.97
- Support Level
- BLNK $1.28
- SCPH $4.33
- Resistance Level
- BLNK $1.44
- SCPH $5.62
- Average True Range (ATR)
- BLNK 0.11
- SCPH 0.04
- MACD
- BLNK 0.03
- SCPH -0.01
- Stochastic Oscillator
- BLNK 81.40
- SCPH 86.67
About BLNK Blink Charging Co.
Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns a majority of revenue from U.S.A.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.